- Home
- UA vs CPRX Comparison
UA vs CPRX Comparison
Compare UA & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UA
- CPRX
- Stock Information
- Founded
- UA 1996
- CPRX 2002
- Country
- UA United States
- CPRX United States
- Employees
- UA N/A
- CPRX N/A
- Industry
- UA Apparel
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- UA Consumer Discretionary
- CPRX Health Care
- Exchange
- UA Nasdaq
- CPRX Nasdaq
- Market Cap
- UA 2.6B
- CPRX 2.9B
- IPO Year
- UA N/A
- CPRX 2006
- Fundamental
- Price
- UA $6.56
- CPRX $21.62
- Analyst Decision
- UA
- CPRX Strong Buy
- Analyst Count
- UA 0
- CPRX 6
- Target Price
- UA N/A
- CPRX $32.83
- AVG Volume (30 Days)
- UA 2.7M
- CPRX 1.4M
- Earning Date
- UA 08-07-2025
- CPRX 08-06-2025
- Dividend Yield
- UA N/A
- CPRX N/A
- EPS Growth
- UA N/A
- CPRX 178.13
- EPS
- UA N/A
- CPRX 1.57
- Revenue
- UA $5,164,310,000.00
- CPRX $534,645,999.00
- Revenue This Year
- UA N/A
- CPRX $16.37
- Revenue Next Year
- UA $2.72
- CPRX $8.80
- P/E Ratio
- UA N/A
- CPRX $13.78
- Revenue Growth
- UA N/A
- CPRX 29.97
- 52 Week Low
- UA $4.62
- CPRX $15.34
- 52 Week High
- UA $10.62
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- UA 52.83
- CPRX 40.61
- Support Level
- UA $6.54
- CPRX $20.62
- Resistance Level
- UA $6.88
- CPRX $21.62
- Average True Range (ATR)
- UA 0.24
- CPRX 0.63
- MACD
- UA -0.02
- CPRX 0.06
- Stochastic Oscillator
- UA 35.62
- CPRX 52.08
About UA Under Armour Inc. Class C
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).